BMS_IM101-863
24.01.2022
A Phase 3, Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA...
Klinische Forschung -
24.01.2022 - 17.01.2025
Abgeschlossen
Projektleitung: Rubbert-Roth Andrea
Mitarbeiter/innen: Peischl Shirin, Peischl Riana, Bartz-Batliner Mira, Haller Christoph, Pirker Ian, Hutz Carina Liane
Weiter